Fulcrum Therapeutics, Inc. - 8-K Filing

Fulcrum Therapeutics enters asset purchase agreement to sell early-stage HbF assets for $7.0 million in cash. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $FULC

Read the full article at SEC EDGAR

More Regulatory news